Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |